195 related articles for article (PubMed ID: 34595124)
1. Editorial: Pathophysiological Interrelationship Between Obesity, Metabolic Diseases, and Cancer.
Gahete MD; Granata R; Luque RM
Front Oncol; 2021; 11():755735. PubMed ID: 34595124
[No Abstract] [Full Text] [Related]
2. Links between aldosterone excess and metabolic complications: A comprehensive review.
Bothou C; Beuschlein F; Spyroglou A
Diabetes Metab; 2020 Feb; 46(1):1-7. PubMed ID: 30825519
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries.
Ierardi E; Rosania R; Zotti M; Principe S; Laonigro G; Giorgio F; de Francesco V; Panella C
World J Gastrointest Pathophysiol; 2010 Aug; 1(3):91-6. PubMed ID: 21607146
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.
Quagliariello V; Rossetti S; Cavaliere C; Di Palo R; Lamantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Romano FJ; Piscitelli R; Iovane G; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; Iaffaioli RV; Facchini G
Oncotarget; 2017 May; 8(18):30606-30616. PubMed ID: 28389628
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Visceral Fat Accumulation and Metabolome Markers among Cats of Varying BCS and Novel Classification of Feline Obesity and Metabolic Syndrome.
Okada Y; Kobayashi M; Sawamura M; Arai T
Front Vet Sci; 2017; 4():17. PubMed ID: 28261588
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome.
Ren J; Anversa P
Biochem Pharmacol; 2015 Feb; 93(4):409-17. PubMed ID: 25541285
[TBL] [Abstract][Full Text] [Related]
7. The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.
Milovanovic T; Pantic I; Dragasevic S; Lugonja S; Dumic I; Rajilic-Stojanovic M
J Gastrointestin Liver Dis; 2021 Jun; 30(2):274-282. PubMed ID: 33951119
[TBL] [Abstract][Full Text] [Related]
8. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
Chen J; Townsend RR
Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
Han L; Bittner S; Dong D; Cortez Y; Bittner A; Chan J; Umar M; Shen WJ; Peterson RG; Kraemer FB; Azhar S
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165688. PubMed ID: 31987840
[TBL] [Abstract][Full Text] [Related]
10. Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk.
Bozzetto L; Costabile G; Della Pepa G; Ciciola P; Vetrani C; Vitale M; Rivellese AA; Annuzzi G
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037123
[TBL] [Abstract][Full Text] [Related]
11. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.
Silveira EA; da Silva Filho RR; Spexoto MCB; Haghighatdoost F; Sarrafzadegan N; de Oliveira C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919368
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development - from basic research to translational applications.
Kung CP; Barnoud T; Yao CH; Murphy ME
Front Endocrinol (Lausanne); 2023; 14():1168700. PubMed ID: 36936168
[No Abstract] [Full Text] [Related]
13. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.
Mili N; Paschou SA; Goulis DG; Dimopoulos MA; Lambrinoudaki I; Psaltopoulou T
Endocrine; 2021 Dec; 74(3):478-497. PubMed ID: 34625915
[TBL] [Abstract][Full Text] [Related]
14. [The role of obesity in the pathogenesis of benign prostatic hyperplasia].
Bratchikov OI; Tyuzikov IA; Artishchev SO; Shumakova EA
Urologiia; 2020 Apr; (2):101-106. PubMed ID: 32351071
[TBL] [Abstract][Full Text] [Related]
15. [Body weight and bone/calcium metabolism. Bone and calcium metabolism in metabolic syndrome.].
Kanazawa I; Sugimoto T
Clin Calcium; 2018; 28(7):897-905. PubMed ID: 29950541
[TBL] [Abstract][Full Text] [Related]
16. Towards a "metabolic" subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction.
Liu CS; Carvalho AF; McIntyre RS
CNS Neurol Disord Drug Targets; 2014; 13(10):1693-707. PubMed ID: 25470395
[TBL] [Abstract][Full Text] [Related]
17. The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone.
Motamedi S; Karimi I; Jafari F
Metab Brain Dis; 2017 Jun; 32(3):651-665. PubMed ID: 28361262
[TBL] [Abstract][Full Text] [Related]
18. Resistin- and Obesity-associated metabolic diseases.
Lazar MA
Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
[TBL] [Abstract][Full Text] [Related]
19. Obesity, metabolic syndrome, and prostate cancer.
Hsing AW; Sakoda LC; Chua S
Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
[TBL] [Abstract][Full Text] [Related]
20. Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments.
O'Sullivan J; Lysaght J; Donohoe CL; Reynolds JV
Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):699-714. PubMed ID: 30323319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
